Danaher (DHR)
(Real Time Quote from BATS)
$268.08 USD
0.00 (0.00%)
Updated Aug 15, 2024 12:42 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Brokerage Reports
Danaher Corporation [DHR]
Reports for Purchase
Showing records 61 - 80 ( 505 total )
Company: Danaher Corporation
Industry: Diversified Operations
2Q23 Bioprocess Bottom Allows a Look into 2024 Possibilities
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 72123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 71123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
GLP-1 Market Opportunity Update, 2028 Consensus Estimates +11% vs. April Report
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Lowering FY23 from HSD to MSD Despite Impressive 1Q23; Our LT View Unchanged
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
1Q23 Includes Lower Guide, but Bioprocess Remains LT Growth Driver
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 41123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Obesity/Diabetes Therapeutics, Far Surpassing Estimates
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 4123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 32123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 31123
Provider: Stock Traders Daily
Analyst: Research Department